SEC Form 4 · accession 0001415889-16-004266
INNOVUS PHARMACEUTICALS, INC. · INNV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Jemil Esber
Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 6:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F1,F2 | — | Jan 4, 2016 | A | 85,714 | A | — | — | Common Stock | 85,714 | 241,729 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- F2The Reporting Person was granted a Restricted Stock Unit award on January 4, 2016 of 85,714 shares, which were fully vested on the date of the grant.
- F3These restricted stock units were granted pursuant to the Issuer's 2013 Equity Incentive Plan.